Allena Pharmaceuticals, Inc.
ALNADelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001624658
Allena Pharmaceuticals, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Feb 2, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.71M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Allena Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 28 | 25 | −3 |
| Shares | 8.05M | 8.95M | +900.6K (+11.2%) |
| Value | $1.86M | $1.71M | −$156.0K (−8.4%) |
New holders (5)
Institutions that held Allena Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acadian Asset Management LLC | 1,250,988 | $239.0K | 0.00% |
| Two Sigma Securities, LLC | 357,044 | $68.0K | 0.01% |
| Millennium Management LLC | 173,798 | $33.0K | 0.00% |
| Renaissance Technologies LLC | 17,200 | $3.00K | 0.00% |
| 1620 Investment Advisors, Inc. | 15,000 | $3.00K | 0.00% |
Sold out (8)
Institutions that held Allena Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Frazier Management LLC | 1,019,288 | $236.0K |
| Bridgeway Capital Management, LLC | 124,200 | $29.0K |
| Virtu Financial LLC | 43,414 | $10.0K |
| Citadel Advisors LLC | 37,613 | $9.00K |
| Jane Street Group, LLC | 12,558 | $3.00K |
| RFG Advisory, LLC | 11,000 | $3.00K |
| Victory Capital Management Inc | 10,745 | $2.00K |
| Tower Research Capital LLC (TRC) | 10,645 | $2.00K |